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Submitted Jul 26, 2012; accepted Oct 10, 2012.INVITED COMMENTARYAhmed M. Abou-Zamzam Jr, MD, Loma Linda, CalifHolden et al describe the initial series of patients treated with
a new endovascular platform termed the Ventana by Endologix
(Irvine, Calif). This investigational platform allows the treatment
of aneurysms with short or absent infrarenal necks (juxtarenal or
pararenal aneurysms). As surgeons have become more aggressive
with endovascular aneurysm repair, the true anatomic “noncandi-
dates” have been disappearing. Although technology has advanced
to the point where iliac anatomy is rarely a contraindication to
endovascular repair, the infrarenal neck is often the limiting factor.
There are currently many devices and techniques emerging for
the treatment of “short necks.” The vascular community awaits
a true answer, as “snorkeling” and “surgeon-modiﬁed” devices
have inherent limitations. Other approaches such as sac-
anchoring devices and endostaples have been proposed, but data
remain limited. The most promising devices currently are
“custom-made” and require time for manufacturing. The Ventana
device, as proposed, represents a novel platform for a truly “off-
the-shelf” treatment of juxtarenal and pararenal aneurysms
(potentially including ruptured aneurysms).
Although the data are good, this report describes only 15
patients and has limited follow-up with only eight patients fol-
lowed for more than 6 months. There is the expected 100%technical success rate and the absence of type I and type III endo-
leaks. The clear appeal of the system is the ability to treat numerous
aneurysms effectively with a limited number of conﬁgurations. In
the current series, only four different devices were used to treat
the 15 patients.
There are certain aspects of the Ventana that warrant discus-
sion. The design of the graft, similar to the Endologix Powerlink
infrarenal device, consists of an endoskeleton with the graft mate-
rial freely ﬂoating. This device design ideally allows for greater
conformability and maneuverability of the fenestrations within
the visceral segment. This design is less rigid than the current
custom-made branched devices and allows a limited number of
conﬁgurations to treat numerous anatomies. However, whether
this design will offer durability in the long term remains to be
seen.
The attraction of the Ventana lies in the stepwise advance of
technology to an already receptive audience. The early results are
encouraging. The complexity of the device mandates that this be
used only by specialists with extensive endovascular aneurysm
repair experience. As all the branched and sac-anchoring devices
evolve and data become available, it will be interesting to see where
the Ventana ﬁnds its niche.
